August 03, 2011
An investor hit Chinese drugmaker Jiangbo Pharmaceuticals Inc., which went public via reverse merger in 2007, with a proposed class action in Florida on Tuesday claiming its executives crowed about its finances in illegitimate public filings, enticing investors to buy "worthless" shares.